Jiangxi Rimag (HKG:2522) has entered into a loan facility agreement to provide financial assistance of up to 44 million yuan to its subsidiaries Rimag Yuntai and Wuhan Ronggongshe, according to a Thursday Hong Kong bourse filing.
The facility represents the total drawdown limit available to the two borrowers and carries an annual interest rate of up to 6%.
The medical imaging firm said the financial assistance is intended to support the subsidiaries' business operations and expansion in medical device sales, leasing, and imaging services.
Rimag Yuntai is 51%-owned by Jiangxi Rimag, while Wuhan Ronggongshe is 51%-owned by a wholly owned subsidiary of the group, the filing said.
Comments